← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Advaita Corporation
Whitmore Lake, MI
$7,379,504
Total funding
7
Grants
Funding over time
peak $896.8K · FY2009–24$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,041,213 · 4
NSF$1,338,291 · 3
By mechanism
R44$3,683,730 · 2
R42$2,211,227 · 1
—$1,338,291 · 3
R41$146,256 · 1
Investigators at Advaita Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
A web-based platform for robust single-cell analysis, bulk data deconvolution and system-level analysis$896,814
R44 · FY2024 · GM
A web-based platform for robust single-cell analysis, bulk data deconvolution and system-level analysis$877,993
R44 · FY2023 · GM
SBIR Phase II: A multi-omics data integration approach for precision medicine and improved clinical trial success$857,298
· FY2019 · TIP
Pathway-Guide: A novel tool for the analysis of signaling and metabolic pathways$749,578
R42 · FY2011 · GM
Pathway-Guide: A novel tool for the analysis of signaling and metabolic pathways$734,239
R42 · FY2012 · GM
Pathway-Guide: A novel tool for the analysis of signaling and metabolic pathways$727,410
R42 · FY2013 · GM
Pathway analysis tools for personalized medicine and drug repositioning$586,812
R44 · FY2016 · GM
Pathway analysis tools for personalized medicine and drug repositioning$586,812
R44 · FY2015 · GM
Pathway analysis tools for personalized medicine and drug repositioning$586,812
R44 · FY2014 · GM
SBIR Phase I: A knowledge base and drug repurposing platform for COVID-19$255,993
· FY2020 · TIP
SBIR Phase I: A multi-omics data integration approach for precision medicine and improved clinical trial success$225,000
· FY2017 · TIP
Pathway analysis tools for personalized medicine and drug repositioning$148,487
R44 · FY2013 · GM
A Novel Method for Signaling Pathway Analysis$146,256
R41 · FY2009 · GM